ClinicalThought

COVID-19 Science Spotlight

Keep up with the fast pace of COVID-19 research with a series of concise “Science Spotlight” commentaries and audio podcasts featuring a pair of experts discussing the most clinically relevant new COVID-19 data.

Christopher J. Lehmann, MD

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Gregory Olson, MD

Renslow Sherer, MD

ClinicalThought

What Is “Severe” COVID-19, and Are the Immunocompromised at Greater Risk?

View ClinicalThought

Here are my thoughts on how developing data may help you assess immunocompromised patients’ risk of severe COVID-19 illness.

Christopher J. Lehmann, MD

Gregory Olson, MD

Renslow Sherer, MD Released: June 10, 2021

ClinicalThought

COVID-19 in Immunocompromised Patients: Vaccine Responsiveness and the Potential for SARS-CoV-2 Variants in Patients With Prolonged Infection

View ClinicalThought

Navigating what is currently known about responsiveness to COVID-19 vaccines and the potential for SARS-CoV-2 variants in immunocompromised patients.

Christopher J. Lehmann, MD

Gregory Olson, MD

Renslow Sherer, MD Released: June 28, 2021

ClinicalThought

New Data on Monoclonal Antibodies for Prevention and Treatment of COVID-19

View ClinicalThought

Neutralizing antibodies are an attractive strategy for prevention and treatment of COVID-19, particularly for unvaccinated persons and others at high risk of infection. Here’s my take on 2 exciting new studies in this field.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: July 7, 2021

COVID-19 Science Spotlight

What Is “Severe” COVID-19, and Are the Immunocompromised at Greater Risk?

COVID-19 in Immunocompromised Patients: Vaccine Responsiveness and the Potential for SARS-CoV-2 Variants in Patients With Prolonged Infection

New Data on Monoclonal Antibodies for Prevention and Treatment of COVID-19

Leaving the CCO site